Close

Cantor Fitzgerald Starts Fluidigm Corporation (FLDM) at Buy; Taking on The Competition, One Cell At a Time

June 26, 2012 4:32 PM EDT
Get Alerts FLDM Hot Sheet
Price: $3.71 --0%

Rating Summary:
    9 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 18 | New: 16
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on Fluidigm Corporation (NASDAQ: FLDM) with a Buy. PT $17.00.

Analyst, Sung Ji Nam, said, "...we think FLDM has built a highly differentiated product portfolio for the emerging (and potentially significant) market opportunity in single cell genomics. Although the uncertain academic funding environment and increasing competition in the next generation sequencing (NGS) sample prep business could be near-term headwinds, we think FLDM is one of the few companies in the life science tools sector with the potential to deliver 20+% top line growth over the next several years."

Nam said FLDM is facing competition from Illumina (Nasdaq: ILMN) and Life Technologies (Nasdaq: LIFE), but fon't see a meaningful threat near-term.

For an analyst ratings summary and ratings history on Fluidigm Corporation click here. For more ratings news on Fluidigm Corporation click here.

Shares of Fluidigm Corporation closed at $14.72 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Cantor Fitzgerald